Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
This study has been completed.
Study NCT00413751   Information provided by Walter Reed Army Medical Center
First Received: December 19, 2006   No Changes Posted

December 19, 2006
December 19, 2006
 
 
 
 
No Changes Posted
 
 
 
Effect of Brimonidine Tartrate Ophthalmic Solution 0.15% on Pupil Diameter in Normal Eyes
 

The objective of this study is to evaluate the effect of brimonidine tartrate ophthalmic solution 0.15% (Alphagan P) on pupil diameter under different luminance conditions.

 
 
Observational
Longitudinal, Convenience Sample, Prospective Study
Healthy
Drug: Brimonidine tartrate ophthalmic solution 0.15% (Alphagan P)
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Completed
20
 
 

Inclusion Criteria:

  • Adult active duty personnel between 18 and 50 years of age with best corrected visual acuity of 20/20 or better.

Exclusion Criteria:

  • Patients not meeting above stated age criteria
  • Females that are pregnant or lactating (non pregnant females of childbearing potential will have pregnancy test prior to participating in study)
  • History of serious ocular, neurological, cardiovascular disease
  • History of severe systemic disease
  • History of arrhythmias or high blood pressure
  • Patients currently taking any type of ocular or systemic medications except multivitamins.
  • Patients with abnormal pupil shape, Addie's pupil, anisocoria, or abnormal pupil defect.
Both
18 Years to 50 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00413751
 
WRAMC WU #03-23004
Walter Reed Army Medical Center
 
Principal Investigator: KRAIG S. BOWER, MD Walter Reed Army Medical Center
Walter Reed Army Medical Center
December 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP